Cost-Effectiveness of Short Course of Ceftazidime/Avibactam for K. pneumoniae -KPC Bloodstream Infections in Italy.

Ilaria De Benedetto Nour Shbaklo Costanza VicentiniCarla Maria ZottiFrancesco Giuseppe De RosaSilvia Corcione

Published in: Microorganisms (2023)

Our findings highlight additional evidence regarding the cost-effectiveness of CAZ/AVI for policy-makers. We outline that CAZ/AVI could be cost-effective compared to old appropriate antibiotic therapies for KPC-Kp BSI.

Keyphrases

klebsiella pneumoniae
multidrug resistant
escherichia coli
gram negative
public health
healthcare
mental health